Pirfenidone Tablet
Product Images NDC 60505-4682

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 60505-4682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

This information presents the percentage of patients experiencing worsening (decrease) or no decline (increase) in Forced Vital Capacity (%FVC) with Pirfenidone compared to Placebo. It includes data on the absolute change in %FVC from baseline to week 52 for both treatments.*

FDA Label Image

Figure2.jpg (Figure2)

This text appears to be a comparison of the mean change in forced vital capacity (FVC) in milliliters between a group treated with Pirfenidone (n=278) and a group given a placebo (n=277) over different weeks. The values show a decrease in FVC over time for both groups, with the Pirfenidone group potentially showing a smaller decline compared to the placebo group. The data seems to be presented graphically in a chart or plot.*

FDA Label Image

Figure3.jpg (Figure3)

The text provides information on the percentage of patients alive in a study comparing Pirfenidone to a placebo. The data includes the number of patients in each group, hazard ratio, and the survival rates over time. The study involved 623 patients on Pirfenidone and 624 patients on placebo, and the hazard ratio (HR) is 0.75 with a 95% confidence interval of 0.51 to 1.11. The survival rates are depicted graphically over weeks, showing the number of patients at risk in each group.*

FDA Label Image

Lbl267mg90s.jpg (Lbl267mg90s)

This is information about Pirfenidone tablets manufactured by Apotex Corp. Each film-coated tablet contains 267 mg of Pirfenidone. The tablets should be stored between 20-25°C (68-77°F) with excursions permitted between 15-30°C (59-86°F). Dispense in a tight container and keep out of reach of children. The usual dosage can be found in the package insert. The pack contains 90 tablets with the NDC 60505-4681-9.*

FDA Label Image

Lbl801mg90s.jpg (Lbl801mg90s)

This text provides information about the storage instructions and dosage of a medication called Pirfenidone. It states that each tablet contains 468 mg of Pirfenidone and should be stored at a temperature between 20°C to 25°C. The medication is permitted to be stored between 16°C to 30°C. It also advises to dispense the tablets in a tight container and keep them out of reach of children. The usual dosage information is mentioned to be available in the package insert. The text mentions "APOTEX CORP." as the manufacturer of the medication.*

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.